ATENOLOL VIATRIS 50 mg, film-coated tablet scored 30 tablets, CIP 3400930187524
Active ingredients: Atenolol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tablets, CIP 3400930187524orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATENOLOL VIATRIS 50 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Jul 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67005951CIP73018752CIP133400930187524Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATÉNOLOLcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.